AlgoraeRx

Accessible care, Advanced science, a healthier future

A wholly owned subsidiary of Algorae Pharmaceuticals Ltd, focused on addressing unmet local medical and clinical medication supply needs across Australia and New Zealand.

ABOUT alograeRx

Integrated Healthcare From Discovery to Distribution

ABOUT alograeRx

Integrated Healthcare From Discovery to Distribution

ABOUT alograeRx

Integrated Healthcare From Discovery to Distribution

As a wholly owned subsidiary of Algorae Pharmaceuticals Ltd (ASX: 1AI), we’re part of a fully integrated healthcare ecosystem spanning pharmaceutical discovery through to patient distribution.

Our Solutions

Complete Pharmaceutical Access

Access Pathways
SAS, Section 19A, Authorised Prescriber, and Clinical Trial access for urgent therapeutic needs.
Registered Products
TGA and Medsafe NZ registered pharmaceuticals with full regulatory approval.
Global Sourcing
Network of certified manufacturers ensuring reliable access to quality medicines.
Our Unique Approach

Driving Value across Global Healthcare

Our Unique Approach

Driving Value across Global Healthcare

1
Product Expertise
Deep expertise in navigating TGA and Medsafe NZ requirements, ensuring every product consistently meets the highest standards of safety, quality, and efficacy.
2
World-wide Collaborations
Strong relationships with licensed manufacturers and distributors worldwide allow us to source critical medicines when local supply is constrained.
3
Commitment to Patient Care
Ensuring the supply of generic and specialty medications to support medicine affordability and patient care.
Get in Touch

Ready to Access Essentinal Medicines?

Connect With AlgoraeRx

Submit your Inquiry Now!

    About Us

    AlgoraeRx was established in 2025 to improve medication supply for Australians and bring new innovative medications to Australian consumers.

    Contact Info

    Level 23, Rialto South Tower, 525 Collins Street, Melbourne, VIC, 3000